Transaction DateRecipientSharesTypePriceValue
9th September 2020Ii Robert C. Goeltz5,000Open or private purchase$21.57$107,848.50
10th August 2020Terry J Rosen32,050Open or private purchase$23.38$749,402.72
7th August 2020Terry J Rosen11,655Open or private purchase$21.44$249,911.17
31st July 2020William Grossman100Open or private purchase$19.68$1,967.56
31st July 2020William Grossman100Open or private purchase$19.77$1,977.00
22nd June 2020Ii Robert C. Goeltz2,483Payment by withholding$9.67$24,010.61
12th June 2020Jennifer Jarrett2,446Grant/award etc.$0.00
11th June 2020Kathryn E Falberg5,670Grant/award etc.$0.00
5th June 2020Yasunori Kaneko35,000Exercise of derivative$7.99$279,650.00
4th June 2020Yasunori Kaneko3,000Grant/award etc.$0.00
Arcus Biosciences
Arcus Biosciences logo

Arcus Biosciences, Inc. engages in the development and commercialization of immunotherapies. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.

Ticker: RCUS
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1724521
Employees: 139
Exchange: New York Stock Exchange
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals